AIM market takes a hit as C4X looks to delist

The AIM market on the London Stock Exchange took a knock to its reputation on Wednesday after one of the biotechs listed on the exchange said it felt it could raise more capital as a private company and therefore will delist.

C4X Discovery Holdings plc (LSE:C4XD) proposed Wednesday to delist from the Alternative Investment Market after nearly a decade of trading on AIM, citing the company’s low share price as a limitation on its ability to raise capital, despite the potential of the biotech’s pipeline...